Role of increased aortic stiffness in the pathogenesis of heart failure J. CheriyanIan B. Wilkinson OriginalPaper 19 March 2008 Pages: 121 - 126
Therapeutic potential of erythropoietin in cardiovascular disease: Erythropoiesis and beyond B. Daan WestenbrinkAdriaan A. VoorsDirk J. van Veldhuisen OriginalPaper 19 March 2008 Pages: 127 - 133
Acute cardio-renal syndrome: Progression from congestive heart failure to congestive kidney failure Detlef Wencker OriginalPaper 19 March 2008 Pages: 134 - 138
Genetics and pharmacogenetics in heart failure Eric M. SnyderThomas P. OlsonBruce D. Johnson OriginalPaper 19 March 2008 Pages: 139 - 144
Urodilatin: A better natriuretic peptide? David L. Vesely OriginalPaper 19 March 2008 Pages: 147 - 152
Role of adenosine antagonism in the cardio-renal syndrome: Pathophysiology and therapeutic potential Venkataraman RajaramJacob Joseph OriginalPaper 19 March 2008 Pages: 153 - 157
The use of positive inotropes in end-of-life heart failure care Deirdre J. NaumanRay E. Hershberger OriginalPaper 19 March 2008 Pages: 158 - 163
The third heart sound for diagnosis of acute heart failure Michael JohnstonSean P. CollinsAlan B. Storrow OriginalPaper 19 March 2008 Pages: 164 - 169
Assessment of quality of life in severe heart failure Prashant VaishnavaEldrin F. Lewis OriginalPaper 19 March 2008 Pages: 170 - 177